ADIPOQ and obesity disorder: Adiponectin, an anti‐inflammatory adipokine, is significantly downregulated by obesity and inversely correlated with OA progression.(9) In our model, adiponectin levels did not change significantly with diet despite a doubling of percent body fat with HFD.